Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Pharmaceutical Industry Labor Management Association
Lobbying Relationship
Bills mentioned
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
H.R.1425: Patient Protection and Affordable Care Enhancement Act
Sponsor: Angie Craig (D-Minn.)
H.R.3: Elijah E. Cummings Lower Drug Costs Now Act
Sponsor: Frank Pallone (D-N.J.)
H.R.5376: Inflation Reduction Act of 2022
Sponsor: John Yarmuth (D-Ky.)
S.127: Pharmacy Benefit Manager Transparency Act of 2023
Sponsor: Maria Cantwell (D-Wash.)
S.113: Prescription Pricing for the People Act of 2023
Sponsor: Charles E. Grassley (R-Iowa)
H.R.830: Help Ensure Lower Patient Copays Act
Sponsor: Buddy Carter (R-Ga.)
S.1542: DRUG Act
Sponsor: Roger Marshall (R-Kan.)
H.R.4895: Lowering Drug Costs for American Families Act
Sponsor: Frank Pallone (D-N.J.)
H.R.2880: Protecting Patients Against PBM Abuses Act
Sponsor: Buddy Carter (R-Ga.)
H.R.6283: Delinking Revenue from Unfair Gouging Act
Sponsor: Mariannette Miller-Meeks (R-Iowa)
H.R.5378: Lower Costs, More Transparency Act
Sponsor: Cathy McMorris Rodgers (R-Wash.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Patrick Foley | Intern, Rep. Boehlert |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate